McAdam, LLC

Position in IBRX — ImmunityBio, Inc.

CIK 1695490 Philadelphia, PA

Position in IBRX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$187,435

+$22,983 QoQ

Shares Held

21,409

-0.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#228

of 401 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

McAdam, LLC holds $891,103 across 5 Biotechnology names. IBRX ranks #3 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,879	$323,588
2	VRTX	Vertex Pharmaceuticals Inc / Ma	543	$269,724
3	IBRX	ImmunityBio, Inc. This page	21,409	$187,435
4	CGTX	Cognition Therapeutics Inc	64,553	$74,235
5	CMPX	Compass Therapeutics, Inc.	16,494	$36,121

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$187,435	21,409	-0.1%	Shares	Sole	2026-08-04
2026-03-31	$164,452	21,441	+0.1%	Shares	Sole	2026-05-08
2025-12-31	$42,409	21,419	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.